Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07107373 · ClinicalTrials.gov registry record
A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US
A clinical trial of Obstructive Hypertrophic Cardiomyopathy (oHCM), sponsored by Bristol-Myers Squibb.
- Active
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT07107373: Active study of Obstructive Hypertrophic Cardiomyopathy (oHCM), sponsored by Bristol-Myers Squibb.
NCT07107373 is a study of Obstructive Hypertrophic Cardiomyopathy (oHCM) that is active but no longer recruiting, run by Bristol-Myers Squibb. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07107373, a study of Obstructive Hypertrophic Cardiomyopathy (oHCM), is active but no longer recruiting, sponsored by Bristol-Myers Squibb.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the real-world safety and effectiveness of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) initiated on mavacamten at certain high volume HCM centers in the US
Conditions Studied
Interventions
- DRUG Mavacamten
Study Locations (1)
California
- University of California, San Francisco (UCSF) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-12-22 |
| Est. Completion | 2025-12-31 |
What the registry record for NCT07107373 still lists
NCT07107373 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Obstructive Hypertrophic Cardiomyopathy (oHCM) appearing as the primary indexed condition, and to 1 intervention - of which Mavacamten is the first listed.
NCT07107373 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07107373 about?
NCT07107373 is a clinical study titled "A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US". The purpose of this study is to evaluate the real-world safety and effectiveness of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) initiated on mavacamten at certain high volume HCM centers in the US
What is the current status of trial NCT07107373?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2023-12-22. Estimated completion is 2025-12-31.
What conditions does trial NCT07107373 study?
This clinical trial studies the following conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM).
What interventions are being tested in trial NCT07107373?
The interventions under investigation include: Mavacamten (DRUG).
Who is sponsoring clinical trial NCT07107373?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07107373 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Hypertrophic Cardiomyopathy (oHCM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI